412 related articles for article (PubMed ID: 16624621)
21. Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells.
Recchia A; Bonini C; Magnani Z; Urbinati F; Sartori D; Muraro S; Tagliafico E; Bondanza A; Stanghellini MT; Bernardi M; Pescarollo A; Ciceri F; Bordignon C; Mavilio F
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1457-62. PubMed ID: 16432223
[TBL] [Abstract][Full Text] [Related]
22. Regulators split on gene therapy as patient shows signs of cancer.
Check E
Nature; 2002 Oct; 419(6907):545-6. PubMed ID: 12374936
[No Abstract] [Full Text] [Related]
23. Gene therapy. Seeking the cause of induced leukemias in X-SCID trial.
Kaiser J
Science; 2003 Jan; 299(5606):495. PubMed ID: 12543948
[No Abstract] [Full Text] [Related]
24. [Hematopoietic malignancies and gene therapy].
Ozawa K
Gan To Kagaku Ryoho; 2003 Apr; 30(4):478-82. PubMed ID: 12722677
[TBL] [Abstract][Full Text] [Related]
25. The evolution of gene therapy in X-linked severe combined immunodeficiency.
Rans TS; England R
Ann Allergy Asthma Immunol; 2009 May; 102(5):357-62; quiz 363-5, 402. PubMed ID: 19492655
[TBL] [Abstract][Full Text] [Related]
26. Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies.
Goyama S; Kurokawa M
Cancer Sci; 2009 Jun; 100(6):990-5. PubMed ID: 19385966
[TBL] [Abstract][Full Text] [Related]
27. Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency.
McCormack MP; Rabbitts TH
N Engl J Med; 2004 Feb; 350(9):913-22. PubMed ID: 14985489
[No Abstract] [Full Text] [Related]
28. Development of an in vitro cell culture assay system for measuring the activation of a neighbouring gene by the retroviral vector.
Hong Y; Yu SS; Yoon NK; Kang SJ; Lee JT; Kim S; Kim JM; Lee K; Jang JW; Kim S
J Gene Med; 2008 Aug; 10(8):847-54. PubMed ID: 18563862
[TBL] [Abstract][Full Text] [Related]
29. Toxicity of repeated intravenous injection of gene therapeutics for X-CGD in mice.
Lee YM; Choi WH; Kim YB; Ha CS; Song CW; Lee M; Joo CW; Hong Y; Ho SH; Kim S; Kim JM; Koh WS
Hum Exp Toxicol; 2008 May; 27(5):401-7. PubMed ID: 18715886
[TBL] [Abstract][Full Text] [Related]
30. American Society of Gene Therapy meeting. Retroviral vectors: a double-edged sword.
Kaiser J
Science; 2005 Jun; 308(5729):1735-6. PubMed ID: 15961648
[No Abstract] [Full Text] [Related]
31. Safety and efficacy in retrovirally modified haematopoietic cell therapy.
Li Z; Modlich U; Baum C
Best Pract Res Clin Haematol; 2004 Sep; 17(3):493-503. PubMed ID: 15498719
[TBL] [Abstract][Full Text] [Related]
32. Is it going to be SIN?: a European Society of Gene Therapy commentary. Phasing-out the clinical use of non self-inactivating murine leukemia virus vectors: initiative on hold.
Buchholz CJ; Cichutek K
J Gene Med; 2006 Oct; 8(10):1274-6. PubMed ID: 17001625
[TBL] [Abstract][Full Text] [Related]
33. Gene therapy using hematopoietic stem cells.
Kohn DB
Curr Opin Mol Ther; 1999 Aug; 1(4):437-42. PubMed ID: 11713757
[TBL] [Abstract][Full Text] [Related]
34. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.
Sinn PL; Sauter SL; McCray PB
Gene Ther; 2005 Jul; 12(14):1089-98. PubMed ID: 16003340
[TBL] [Abstract][Full Text] [Related]
35. Murine leukemia following irradiation conditioning for transplantation of lentivirally-modified hematopoietic stem cells.
Siapati EK; Bigger BW; Kashofer K; Themis M; Thrasher AJ; Bonnet D
Eur J Haematol; 2007 Apr; 78(4):303-13. PubMed ID: 17378892
[TBL] [Abstract][Full Text] [Related]
36. Is retroviral gene marking too dangerous to use?
Brenner MK; Heslop HE
Cytotherapy; 2003; 5(3):190-3. PubMed ID: 12850996
[No Abstract] [Full Text] [Related]
37. Detection of retroviral integration sites by linear amplification-mediated PCR and tracking of individual integration clones in different samples.
Schmidt M; Schwarzwaelder K; Bartholomae CC; Glimm H; von Kalle C
Methods Mol Biol; 2009; 506():363-72. PubMed ID: 19110638
[TBL] [Abstract][Full Text] [Related]
38. Occurrence of leukaemia following gene therapy of X-linked SCID.
Kohn DB; Sadelain M; Glorioso JC
Nat Rev Cancer; 2003 Jul; 3(7):477-88. PubMed ID: 12835668
[TBL] [Abstract][Full Text] [Related]
39. Good news for gene therapy.
Berns A
N Engl J Med; 2004 Apr; 350(16):1679-80. PubMed ID: 15084702
[No Abstract] [Full Text] [Related]
40. Successes and risks of gene therapy in primary immunodeficiencies.
Chinen J; Puck JM
J Allergy Clin Immunol; 2004 Apr; 113(4):595-603; quiz 604. PubMed ID: 15100660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
